Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and obser...
Saved in:
Published in | European journal of endocrinology Vol. 168; no. 3; pp. 297 - 305 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bristol
BioScientifica
01.03.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.Design and methodsAssociations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.ResultsPP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.ConclusionsGHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. |
---|---|
AbstractList | Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Design and methods: Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values < 0.05 were considered statistically significant. Results: PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. Conclusions: GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. European Journal of Endocrinology 168 297-305 GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant. PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.Design and methodsAssociations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.ResultsPP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.ConclusionsGHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. Objective GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Design and methods Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant. Results PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. Conclusions GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. |
Author | Mattsson, Anders F Góth, Miklós I Abs, Roger Verhelst, Johan Thunander, Maria Kołtowska-Häggström, Maria Wilton, Patrick Luger, Anton |
Author_xml | – sequence: 1 givenname: Roger surname: Abs fullname: Abs, Roger – sequence: 2 givenname: Anders F surname: Mattsson fullname: Mattsson, Anders F – sequence: 3 givenname: Maria surname: Thunander fullname: Thunander, Maria – sequence: 4 givenname: Johan surname: Verhelst fullname: Verhelst, Johan – sequence: 5 givenname: Miklós I surname: Góth fullname: Góth, Miklós I – sequence: 6 givenname: Patrick surname: Wilton fullname: Wilton, Patrick – sequence: 7 givenname: Maria surname: Kołtowska-Häggström fullname: Kołtowska-Häggström, Maria – sequence: 8 givenname: Anton surname: Luger fullname: Luger, Anton |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27158703$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23211573$$D View this record in MEDLINE/PubMed https://lup.lub.lu.se/record/3765151$$DView record from Swedish Publication Index |
BookMark | eNp9kc9rFDEUx4NU7LZ68i65CIKM5udk1puUta2uKKjgLbwkb2hkdmacZCx77x_eDLvWm4dHwjef9328fM_IST_0SMhzzt5wLdnbzcdNxUXFGmYekRVXZl3Vjfx5QlZFUpWqlTwlZyn9YoyXO3tCToUUnGsjV-Tu64R_oMPeIx1aGiI4zJjoDrsu5jnR2NOaaUZv9uMwFiVmmPZ0hByxz4nexnxDIcxdroY-YaaXVzRgG3159nvqsB0mXMQJxw487krXOwr00_XnbxR66PYppqfkcQtdwmfH85z8-LD5fnFVbb9cXl-831ZOa54rpZgQyoCXQrDgmtCKoIwCLmquGKiG-RoCMLEOmtUtMAnMmRqkM1hLUctzsj34plscZ2fHKe7KNnaAaLt5LOVK2YQ2SGUMh8bKoLRV2nsLjqGVmnvkkkNwUOxeHezGafg9Y8p2F5MvHwc9DnOyXDTNeq2VlAV9fUD9NKQ0YfswmzO7pGhLiqXBLikW-sXReHY7DA_s39gK8PIIQPLQtRP0PqZ_nOG6MWzh-IFzcUhLJDmWaOC_w-8ByN62EA |
CitedBy_id | crossref_primary_10_1159_000499430 crossref_primary_10_3389_fendo_2018_00284 crossref_primary_10_1007_s40618_019_01100_y crossref_primary_10_3390_cancers15010055 crossref_primary_10_3390_jcm12020662 crossref_primary_10_1016_j_endonu_2015_01_009 crossref_primary_10_1530_EC_18_0096 crossref_primary_10_3389_fendo_2024_1348046 crossref_primary_10_1152_ajpendo_00420_2014 crossref_primary_10_3389_fendo_2020_569633 crossref_primary_10_1111_cen_12603 crossref_primary_10_1007_s11357_022_00680_7 crossref_primary_10_1210_clinem_dgaa089 crossref_primary_10_1111_cen_13256 crossref_primary_10_3389_fendo_2023_1087053 crossref_primary_10_1507_endocrj_EJ15_0337 crossref_primary_10_1007_s11102_016_0747_9 crossref_primary_10_1210_en_2013_1825 crossref_primary_10_1186_s12902_019_0464_2 crossref_primary_10_1007_s12020_016_1076_5 crossref_primary_10_1155_2022_7853786 crossref_primary_10_1007_s11102_021_01173_0 crossref_primary_10_1007_s12020_016_1183_3 crossref_primary_10_3389_fendo_2018_00358 crossref_primary_10_15406_jdmdc_2014_01_00023 crossref_primary_10_1556_650_2023_32890 crossref_primary_10_1038_s41574_021_00539_5 crossref_primary_10_1002_hep4_1953 crossref_primary_10_3389_fendo_2021_626427 crossref_primary_10_4103_ijem_ijem_297_23 crossref_primary_10_1210_jc_2017_01542 crossref_primary_10_1016_j_endoen_2015_05_002 crossref_primary_10_1111_cen_12477 crossref_primary_10_1007_s11102_022_01207_1 crossref_primary_10_1530_EJE_22_0160 crossref_primary_10_1016_j_ghir_2018_12_001 crossref_primary_10_1210_jc_2014_1013 |
Cites_doi | 10.1210/jc.81.2.555 10.1210/jc.2007-0458 10.1111/j.1464-5491.2007.02106.x 10.1016/j.ghir.2005.06.018 10.1210/jc.83.12.4350 10.2337/dc11-0449 10.1210/jc.2011-0448 10.1080/1740028032000131396 10.1530/EJE-09-0291 10.2337/diab.36.4.523 10.1002/pds.1510 10.1016/S0140-6736(02)08655-5 10.1210/er.2008-0027 10.1530/EJE-11-0599 10.1038/ejcn.2009.93 10.1001/archpedi.1975.02120450026006 10.1042/cs0890321 10.1093/epirev/mxm008 10.2337/diacare.24.9.1522 10.1046/j.1365-2265.1999.00695.x 10.1016/0026-0495(95)90004-7 10.1007/s11102-008-0110-x 10.1210/edrv-8-2-115 10.1210/jcem-61-6-1152 10.1159/000071871 10.1093/aje/kwi188 |
ContentType | Journal Article |
Copyright | 2013 European Society of Endocrinology 2014 INIST-CNRS |
Copyright_xml | – notice: 2013 European Society of Endocrinology – notice: 2014 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 ADTPV AOWAS D95 |
DOI | 10.1530/EJE-12-0807 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic SwePub SwePub Articles SWEPUB Lunds universitet |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Diabetes mellitus in adult-onset GHD |
EISSN | 1479-683X |
EndPage | 305 |
ExternalDocumentID | oai_lup_lub_lu_se_d34771a8_3d45_45cc_ab0e_351ce131adba 10_1530_EJE_12_0807 23211573 27158703 |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GroupedDBID | - 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 5VS AAFZV AAPBV ABLYK ABOCM ABPTK ABSGY ABSQV ACNCT ACPRK ADACO ADBBV ADBIT ADDZX AENEX AFFNX AGCAB ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DU5 E3Z EBS EJD GJ GX1 H13 HZ IL9 INIJC J5H KQ8 L7B O0- O9- OK1 P2P RHF SJN TBS TR2 VH1 WOQ X X7M ZA5 ZGI ZXP --- -~X .55 .GJ 0R~ 18M ACGFO ADGIM AFHIN AI. BTFSW F9R HZ~ IQODW W8F 5WD AABZA AACZT AAPGJ AAPXW AARHZ AAUAY AAVAP AAWDT ABMNT ABNHQ ABPQP ABPTD ABQNK ABWST ABXVV ACFRR ACUTJ ADIPN ADQBN ADVEK AFGWE AFYAG AGQXC AGUTN AJEEA ANFBD APJGH ATGXG BCRHZ CGR CUY CVF ECM EIF EMOBN KOP NPM OAUYM OBOKY OCZFY OJZSN OPAEJ OVD OWPYF ROX TCN TEORI TMA AAYXX CITATION 7X8 ADTPV AOWAS D95 |
ID | FETCH-LOGICAL-b551t-4402247ac3220db8df2d474a126140a480c6ada029d506fa03a0b76a3b7e63263 |
ISSN | 0804-4643 1479-683X |
IngestDate | Sat Aug 24 00:45:18 EDT 2024 Fri Aug 16 23:57:11 EDT 2024 Fri Aug 23 02:57:40 EDT 2024 Sat Sep 28 07:57:01 EDT 2024 Fri Nov 25 06:02:12 EST 2022 Wed Apr 14 02:20:59 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Endocrinopathy Human Replacement therapy Prevalence Diabetes mellitus Deficiency Patient Epidemiology Somatotropin Adenohypophyseal hormone Hypophyseal insufficiency Pituitary diseases Adult Endocrinology |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b551t-4402247ac3220db8df2d474a126140a480c6ada029d506fa03a0b76a3b7e63263 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1530/EJE-12-0807 |
PMID | 23211573 |
PQID | 1288995433 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | swepub_primary_oai_lup_lub_lu_se_d34771a8_3d45_45cc_ab0e_351ce131adba proquest_miscellaneous_1288995433 crossref_primary_10_1530_EJE_12_0807 pubmed_primary_23211573 pascalfrancis_primary_27158703 bioscientifica_primary_10_1530_EJE_12_0807 |
PublicationCentury | 2000 |
PublicationDate | 2013-03-01 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Bristol |
PublicationPlace_xml | – name: Bristol – name: England |
PublicationTitle | European journal of endocrinology |
PublicationTitleAlternate | Eur J Endocrinol |
PublicationYear | 2013 |
Publisher | BioScientifica |
Publisher_xml | – name: BioScientifica |
References | Gutierrez (13_30137256) 2008; 17 Qiao (26_35528359) 2010; 64 Hillier (24_11295352) 2001; 24 (8_45189668) 1995; 89 Brabant (17_17733160) 2003; 60 (20_39828145) 2011; 96 (7_35411243) 2009; 161 Johansson (9_16000472) 1995; 44 (3_28235338) 1989; 256 (28_35824394) 2005; 15 (14_35824399) 2003; 1 Harris (22_14064530) 1987; 36 (1_39932134) 2009; 30 BOUGNERES (6_13645348) 1985; 61 (19_19264965) 2005; 162 (21_29015811) 2007; 92 Cordido (11_6261237) 1998; 83 Bennett (29_27989582) 2007; 24 (30_41190729) 2012; 35 Hopwood (5_20126848) 1975; 129 (15_36172415) 2008; 11 (25_28549156) 2007; 29 (23_40892942) 2011; 165 DAVIDSON (2_14204025) 1987; 8 (4_45189667) 1991; 260 Hew (10_16231559) 1996; 81 Sandhu (27_17087722) 2002; 359 Abs (12_10946879) 1999; 50 |
References_xml | – volume: 81 start-page: 555 issn: 0021-972X issue: 2 year: 1996 ident: 10_16231559 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.81.2.555 contributor: fullname: Hew – volume: 92 start-page: 3560 issn: 0021-972X issue: 9 year: 2007 ident: 21_29015811 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2007-0458 – volume: 24 start-page: 333 issn: 0742-3071 issue: 4 year: 2007 ident: 29_27989582 publication-title: Diabetic medicine : a journal of the British Diabetic Association doi: 10.1111/j.1464-5491.2007.02106.x contributor: fullname: Bennett – volume: 15 start-page: 349 year: 2005 ident: 28_35824394 publication-title: GROWTH HORMONE IGF RESEARCH doi: 10.1016/j.ghir.2005.06.018 – volume: 83 start-page: 4350 issn: 0021-972X issue: 12 year: 1998 ident: 11_6261237 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.83.12.4350 contributor: fullname: Cordido – volume: 35 start-page: 57 issn: 0149-5992 issue: 1 year: 2012 ident: 30_41190729 publication-title: Diabetes Care doi: 10.2337/dc11-0449 – volume: 96 start-page: 2255 issn: 0021-972X issue: 7 year: 2011 ident: 20_39828145 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2011-0448 – volume: 256 start-page: E835 issn: 0002-9513 year: 1989 ident: 3_28235338 publication-title: American Journal of Physiology -- Legacy Content – volume: 1 start-page: 15 year: 2003 ident: 14_35824399 publication-title: NEW REVIEW OF BIOETHICS doi: 10.1080/1740028032000131396 – volume: 161 start-page: S41 issn: 0804-4643 issue: suppl_1 year: 2009 ident: 7_35411243 publication-title: European Journal of Endocrinology doi: 10.1530/EJE-09-0291 – volume: 36 start-page: 523 issn: 0012-1797 issue: 4 year: 1987 ident: 22_14064530 publication-title: Diabetes doi: 10.2337/diab.36.4.523 contributor: fullname: Harris – volume: 17 start-page: 90 issn: 1053-8569 issue: 1 year: 2008 ident: 13_30137256 publication-title: Pharmacoepidemiology and drug safety doi: 10.1002/pds.1510 contributor: fullname: Gutierrez – volume: 359 start-page: 1740 issn: 0140-6736 issue: 9319 year: 2002 ident: 27_17087722 publication-title: Lancet doi: 10.1016/S0140-6736(02)08655-5 contributor: fullname: Sandhu – volume: 30 start-page: 152 issn: 0163-769X issue: 2 year: 2009 ident: 1_39932134 publication-title: Endocrine Reviews doi: 10.1210/er.2008-0027 – volume: 165 start-page: 881 issn: 0804-4643 issue: 6 year: 2011 ident: 23_40892942 publication-title: European Journal of Endocrinology doi: 10.1530/EJE-11-0599 – volume: 64 start-page: 30 issn: 1476-5640 issue: 1 year: 2010 ident: 26_35528359 publication-title: European Journal of Clinical Nutrition doi: 10.1038/ejcn.2009.93 contributor: fullname: Qiao – volume: 129 start-page: 918 issn: 0096-8994 issue: 8 year: 1975 ident: 5_20126848 publication-title: Archives of Pediatrics and Adolescent Medicine doi: 10.1001/archpedi.1975.02120450026006 contributor: fullname: Hopwood – volume: 89 start-page: 321 issn: 0009-9287 year: 1995 ident: 8_45189668 publication-title: Clinical science doi: 10.1042/cs0890321 – volume: 29 start-page: 115 issn: 0193-936X issue: 1 year: 2007 ident: 25_28549156 publication-title: Epidemiologic Reviews doi: 10.1093/epirev/mxm008 – volume: 24 start-page: 1522 issn: 0149-5992 issue: 9 year: 2001 ident: 24_11295352 publication-title: Diabetes Care doi: 10.2337/diacare.24.9.1522 contributor: fullname: Hillier – volume: 260 start-page: E395 issn: 0002-9513 year: 1991 ident: 4_45189667 publication-title: American Journal of Physiology -- Legacy Content – volume: 50 start-page: 703 issn: 0300-0664 issue: 6 year: 1999 ident: 12_10946879 publication-title: Clinical endocrinology doi: 10.1046/j.1365-2265.1999.00695.x contributor: fullname: Abs – volume: 44 start-page: 1126 issn: 0026-0495 issue: 9 year: 1995 ident: 9_16000472 publication-title: Metabolism: clinical and experimental doi: 10.1016/0026-0495(95)90004-7 contributor: fullname: Johansson – volume: 11 start-page: 121 issn: 1573-7403 year: 2008 ident: 15_36172415 doi: 10.1007/s11102-008-0110-x – volume: 8 start-page: 115 issn: 0163-769X issue: 2 year: 1987 ident: 2_14204025 publication-title: Endocrine Reviews doi: 10.1210/edrv-8-2-115 contributor: fullname: DAVIDSON – volume: 61 start-page: 1152 issn: 0021-972X issue: 6 year: 1985 ident: 6_13645348 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jcem-61-6-1152 contributor: fullname: BOUGNERES – volume: 60 start-page: 53 issn: 0301-0163 issue: 2 year: 2003 ident: 17_17733160 publication-title: Hormone research doi: 10.1159/000071871 contributor: fullname: Brabant – volume: 162 start-page: 199 issn: 0002-9262 issue: 3 year: 2005 ident: 19_19264965 publication-title: American Journal of Epidemiology doi: 10.1093/aje/kwi188 |
SSID | ssj0016430 |
Score | 2.2976608 |
Snippet | ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus... GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose... Objective GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus... OBJECTIVEGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus... Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus... |
SourceID | swepub proquest crossref pubmed pascalfrancis bioscientifica |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 297 |
SubjectTerms | Adult Age of Onset Aged Biological and medical sciences Body Mass Index Clinical Medicine Clinical Study Cohort Studies Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - etiology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinology and Diabetes Endocrinopathies Endokrinologi och diabetes Epidemiology Etiopathogenesis. Screening. Investigations. Target tissue resistance Europe - epidemiology Female Fundamental and applied biological sciences. Psychology General aspects Glycated Hemoglobin A - analysis Human Growth Hormone - deficiency Humans Hypopituitarism - blood Hypopituitarism - complications Hypopituitarism - physiopathology Klinisk medicin Male Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Middle Aged Overweight - complications Poisson Distribution Prevalence Public health. Hygiene Public health. Hygiene-occupational medicine Sex Factors United States - epidemiology Vertebrates: endocrinology Young Adult |
Title | Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis |
URI | http://dx.doi.org/10.1530/EJE-12-0807 https://www.ncbi.nlm.nih.gov/pubmed/23211573 https://search.proquest.com/docview/1288995433 https://lup.lub.lu.se/record/3765151 |
Volume | 168 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAIEGwDymUy0sQDVUYSO5fyVqHSMjSeOrS3yI4dWokmUZs-jGf-Av-XcxwnaWFDwEOjynESqd8Xn0u_c0zIsR8qXwuIVLniWJKjhCPTlDng6UqZxdgiDAuFzz6F03N-ehFc9Ho_tlRLm0qepN-urCv5H1RhDHDFKtl_QLa9KQzAd8AXjoAwHP8KY-y_JEzVEPp8bRp1iU02q41RukIc4Q7ml2VRwsiiQo2cbaXa1LVhAw4HNdXVYDIdKI0tJUw9ptTg0GocXGkj3WoSiWLw8QPE_8L2M7k2uW8dXZ2rAtam3QT-SNYpnuJLJw_GvcfXtgJsZIpuOt3xbL4x-e6VLTBatObks17NwcBXVlhs2W4TGbipRKPkOtH14sujoRPGZn_gbnUO4y0asu21thb2_mYDAoaiyfHp2KhOYndnFvxK5dLQAVxJbDTEOkPYyhObUzfITT8aBqgUnVy0yiEIMJlrSz3hWW-2noStpe21d8g9uaj7kRrR167jc7cUa3gHs3rzlKuim19a1xp3Z_aA3LdxCh3VpHtIejrfJwejXFTF8pK-okY5bBDdJ7fOrEDjgHzvKEmLjDaUpA0l6SKnSEm6Q0naUJIiJekWJelkSjtK0pqSOLhFybdUUCQkbQh5SM7fj2fvpo7d6MOR4LBXDufoSUYiBeviKhmrzFc84sKD8J67gsduGgolXH-oAjfMhMuEK6NQMBnpEOIP9ojs5UWunxAaazYEu5TGQmQ89LQc8kyozFNRxDztqj55vQtLUtZdXRKMhgHOBOBMPD9BOPvkuIHsz9OOduBs5_qRF4A9ZH3yssE3gdUb_5ITuS42a7hDHGNHRgZzHtfAd1dbJvXJuGZCewZbwn_dlPCR8EnWOlGMR5En4oQpHiQ8SNNESFcnLPBS7TFPKCmeXvuEZ-R290I-J3vVaqNfgK9dySPD_J9cd9aR |
link.rule.ids | 230,315,786,790,891,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+diabetes+mellitus+in+6050+hypopituitary+patients+with+adult-onset+GH+deficiency+before+GH+replacement%3A+a+KIMS+analysis&rft.jtitle=European+journal+of+endocrinology&rft.au=Abs%2C+Roger&rft.au=Mattsson%2C+Anders+F&rft.au=Thunander%2C+Maria&rft.au=Verhelst%2C+Johan&rft.date=2013-03-01&rft.eissn=1479-683X&rft.volume=168&rft.issue=3&rft.spage=297&rft_id=info:doi/10.1530%2FEJE-12-0807&rft_id=info%3Apmid%2F23211573&rft.externalDocID=23211573 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon |